Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | FAAH | O00519 | 2/20 | 0.62 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.62 |
| ▸ | PPARA | Q07869 | 2/20 | 0.57 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | ADH1B | P00325 | 1/20 | 0.52 |
| ▸ | ADH1C | P00326 | 1/20 | 0.52 |
| ▸ | ADH1A | P07327 | 1/20 | 0.52 |
| ▸ | ADH4 | P08319 | 1/20 | 0.52 |
| ▸ | ADH7 | P40394 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 6/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9480001 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL518802 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL9208641 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL6677501 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL519455 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL11786437 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL23117202 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL518800 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL22063916 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL296807 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009020430-A2 | METHOD OF FORMING A CADMIUM CONTAINING NANOCRYSTAL | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-02-12 | — | — | WO | claimed |
| EP-1513638-B1 | METAL POWDER COMPOSITION INCLUDING A BONDING LUBRICANT AND A BONDING LUBRICANT COMPRISING GLYCERYL STEARATE. | HOEGANAES AB (SE) | 2008-08-20 | — | — | EP | claimed |
| US-20080090742-A1 | Compound and method of making the compound | AFTON CHEMICAL CORPORATION | 2008-04-17 | — | — | US | claimed |
| EP-0960224-B1 | SPANDEX WITH LOW TACKINESS AND PROCESS FOR MAKING SAME | DU PONT (US) | 2001-12-12 | — | — | EP | claimed |
| US-6268534-B1 | CONTACTING OLEYL BROMIDE WITH OLEYLAMINE UNDER CONDITIONS SUITABLE FOR THE FORMATION OF N,N-DIOLEYLAMINE; METHYLATION OF N,N-DIOLEYLAMINE UNDER CONDITIONS SUITABLE FOR FORMATION OF N,N-DIOLEYL-N,N-DIMETHYLAMMONIUM CHLORIDE | RIBOZYME PHARMACEUTICALS, INC. | 2001-07-31 | — | — | US | claimed |
| EP-3262147-B1 | AROMATIC DETERGENTS AND LUBRICATING COMPOSITIONS THEREOF | LUBRIZOL CORP (US) | 2025-01-22 | — | — | EP | disclosed |
| EP-3390591-B1 | LUBRICATING COMPOSITIONS COMPRISING SULFURIZED CATECHOLATE DETERGENTS | LUBRIZOL CORP (US) | 2024-10-30 | — | — | EP | disclosed |
| US-11633365-B2 | Nucleic acid-containing lipid nanoparticle | KYOWA KIRIN CO., LTD. (JP) | 2023-04-25 | — | — | US | disclosed |
| EP-3209756-B1 | DISPERSANT VISCOSITY MODIFIERS WITH SULFONATE FUNCTIONALITY | LUBRIZOL CORP (US) | 2022-11-02 | — | — | EP | disclosed |
| US-11149226-B2 | Preparation and use of aminoalkylphosphonic acid dialkyl ester compounds in a lubricant for antiwear, friction reduction, and/or micropitting prevention | AFTON CHEMICAL CORPORATION (US) | 2021-10-19 | — | — | US | disclosed |
| US-20210309932-A1 | Lubricating Compositions | THE LUBRIZOL CORPORATION (US) | 2021-10-07 | — | — | US | disclosed |
| EP-3480256-B1 | POLYAMIDE RESIN MOLDED ARTICLE | ASAHI CHEMICAL IND (JP) | 2021-05-05 | — | — | EP | disclosed |
| EP-0519760-A1 | Oil additive concentrates and lubricants of enhanced performance capabilities | ETHYL PETROLEUM ADDITIVES, INC. (US) | 1992-12-23 | — | — | EP | disclosed |
| US-4941983-A | Fluid loss-reducing additives for oil-based well working fluids | SANDOZ LTD. (CH) | 1990-07-17 | — | — | US | disclosed |
| EP-0259266-A2 | Improvements in or relating to organic compounds | SANDOZ AG (CH) | 1988-03-09 | — | — | EP | disclosed |
| EP-0049484-B1 | A PROCESS FOR THE PRODUCTION OF A FLUID LOSS REDUCING ADDITIVE FOR AN OIL-BASED WELL WORKING FLUID | B W MUD LIMITED (GB) | 1984-12-19 | — | — | EP | disclosed |
| US-4371446-A | COMPOSED OF DUOMEEN-T-DIOLEATE AND A DIAMIDE | NIPPN OIL COMPANY, LTD. (JP) | 1983-02-01 | — | — | US | disclosed |
| EP-0049484-A1 | A process for the production of a fluid loss reducing additive for an oil-based well working fluid | B W MUD LIMITED (GB) | 1982-04-14 | — | — | EP | disclosed |
| US-3995059-A | CHOLESTEROL LOWERING AGENTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-11-30 | — | — | US | disclosed |
| US-3960613-A | Wax-flux composition containing amine salts of carboxylic acids for soldering | CHEVRON RESEARCH COMPANY (US) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11633365-B2 | Nucleic acid-containing lipid nanoparticle | LIPA, LIPC, PNLIP | TSHR 3238/4885ALDH1A1 354/4885FAAH 89/4885 |
| US-11149226-B2 | Preparation and use of aminoalkylphosphonic acid dialkyl ester compounds in a lubricant for antiwear, friction reduction, and/or micropitting prevention | TP53RK, PHOSPHO1, PTAFR | TSHR 2938/4885ALDH1A1 3134/4885FAAH 1898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.